Inventiva announces the presentation of a scientific abstract at the next International Conference on Fatty Liver
07 avr. 2022 16h00 HE
|
INVENTIVA
Daix (France), Long Island City (New York, United States), April 7, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral...
Flow Therapy Adds World-Renowned Cardiologist Timothy D. Henry to Board of Directors
06 avr. 2022 09h00 HE
|
Flow Therapy
FORT WORTH, Texas, April 06, 2022 (GLOBE NEWSWIRE) -- World-renowned cardiologist Timothy D. Henry, MD, FACC, MSCAI, has joined Flow Therapy's Board of Directors. Dr. Henry is the Lindner Family...
Inventiva annonce que la FDA accepte sa demande d’« Investigational New Drug » pour l’essai clinique de Phase II combinant lanifibranor et empagliflozine chez des patients atteints de la NASH et de diabète de type 2
08 mars 2022 02h00 HE
|
INVENTIVA
L’évaluation de la Food and Drug Administration (FDA) est favorable à la poursuite de l’essai clinique combiné LEGEND Le lancement de l’étude est prévu pour S1 2022 et la publication des premiers...
Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA
08 mars 2022 02h00 HE
|
INVENTIVA
FDA assessment concludes that the Phase II combination trial, LEGEND, may proceed The initiation of the trial is planned for H1 2022 and the publication of topline results is expected for H2 2023 ...
Reprocessed Medical Devices Market ($4.5Bn by 2028) Growth Forecast at 14.5% CAGR During 2022 to 2028 COVID Impact and Global Analysis by Vantage Market Research
01 mars 2022 02h40 HE
|
Vantage Market Research
WASHINGTON, March 01, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Reprocessed Medical Devices Market finds that increasing the adoption of Reprocessed Medical...
CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
15 févr. 2022 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Feb. 15, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
Dental Care Medical Ceramics Market to Grow at a CAGR of Nearly 6% by 2031: Comprehensive Research by Fact.MR
15 févr. 2022 15h30 HE
|
FACT.MR
ROCKVILLE, Md., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Rise in application in various medical fields such as dental implants, bone implants, and kidney dialysis machines and equipment has been fuelling...
Positive Results for Lipid inCode® in NHS Clinical Study
15 févr. 2022 02h00 HE
|
GENinCode Plc
OXFORD, England, Feb. 15, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion...
Radcliffe Group Launches New Branding to Signal the Start of a Year of Innovation and Investment
10 févr. 2022 10h09 HE
|
Radcliffe Group Ltd
LONDON, England, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Radcliffe Group has unveiled a new brand identity across its core business, including its three specialist channels: Radcliffe Cardiology,...
Global Cardiovascular Needle and Prosthetic Devices Market Trend of 2022 with Insights Research Report, Share By Type, Size By End User, Exploring Sales Volume Revenue, Comprehensive Growth And Forecast 2027
10 févr. 2022 08h42 HE
|
360 Market Updates
Pune, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Part 1 : Global Cardiovascular Needle Market The report provides in-depth analysis and insights into the current global market scenario, latest trends,...